MedPath

SANDOZ PHARMACEUTICALS D.D.

🇱🇧Lebanon
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

CIMA_AEMPS:7
EMA:5
NMPA:2

Drug Approvals

Entecavir Tablets

Product Name
恩替卡韦片
Approval Number
国药准字HJ20210015
Approval Date
Mar 23, 2021
NMPA

Entecavir Tablets

Product Name
恩替卡韦片
Approval Number
国药准字HJ20210016
Approval Date
Mar 23, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.